NeurologyLive® Friday 5 — January 14, 2022

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending January 14, 2022.

Welcome to NeurologyLive®'s Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive®'s widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.

1: CMS Releases Proposed Decision for Aducanumab Coverage in Alzheimer Disease

The Centers for Medicare and Medicaid Services issued a proposed decision memo detailing the coverage criteria for patients with Alzheimer disease to be covered by the federal health insurance platform when administered aducanumab (Aduhelm; Biogen)..

2: Podcast Episode 55: Treating Headache in the Emergency Department

Mind Moments™, a podcast from NeurologyLive®, brings you an exclusive interview with Anne-Maree Kelly, MD, MClinEd, FACEM, who shared her clinical experience treating patients with headache and migraine in the emergency department (ED), offering insight into the factors that influence patient outcomes and the vital need for consensus international guidelines for ED migraine care.

3: NeuroVoices: Irene Wang, PhD, on the Clinical Utility of MR Fingerprinting in Epilepsy

The research director and staff scientist at Cleveland Clinic’s Epilepsy Center discussed why MR fingerprinting holds significant clinical potential in epilepsy and epilepsy-related disorders, and discussed how this approach is different from other typical standard MRIs, which may be limited in capacity for some forms of epilepsy.

4: Peer Exchange: Considering Sleep Studies for Insomnia

Michael J. Thorpy, MD, ChB; Karl Doghramji, MD; Erinn E. Beagin, MD; Nathaniel Fletcher Watson, MD; and Vikas Jain, MD, FAASM, FAAFP, CCSH, CPE, offer a brief review of the value of polysomnography, or sleep studies, in diagnosing patients with insomnia, in episode 5 of this NeurologyLive® Peer Exchange, "Unmet Needs in Treating Insomnia."

5: Pros and Cons of Telemedicine for Multiple Sclerosis: Mitzi Joi Williams, MD

The founder and CEO of Joi Wellness Group Multiple Sclerosis Center explained her experience with telemedicine in her practice and expressed her hope that telemedicine, as well as the collaborative approach within the comprehensive care model generated during the pandemic, are both here to stay.

—————————————————
Introducing: Giants of Multiple Sclerosis™

Recognize and celebrate the individuals who have achieved landmark successes within multiple sclerosis! Giants of Multiple Sclerosis™ is a premier neuroscience award that celebrates pioneers, innovators, and future generations of leaders who have been selected by their peers for their remarkable achievements in Multiple Sclerosis.

Nominate Someone Today for a 2022 Giants of Multiple Sclerosis™ Award

  • Nominations are open through January 31, 2022
  • The Giants of Multiple Sclerosis™ Steering Committee will vet all nominations and vote to determine the 2022 inductees
  • Nominees will be selected on the merits of their lifetime work.
  • One honoree in each category who makes a measurable difference in the lives of patients will be awarded.
  • The 2022 Giants of Multiple Sclerosis™ inaugural class will be announced in Spring of 2022

Nominate someone here.